COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 2137: Articles 21361-21370  | Next

Duple extinguishment of COVID-19: single compound synergized inhibition of SARS-CoV-2 replication and direct suppression of inflammatory cytokines in vitro/vivo
Gao, X., Gong, Y., Tan, W., Jiang, H., Qi, J., Zhao, J., Sun, B., Gao, X., Gao, X., Cao, P., He, B., Fan, J., Dong, Y., Gao, F., Yuan, Q., Gao, Y., Zhao, W., Zhang, C., Du, Z., Ye, F., He, Z.
10.1101/2020.10.16.342097 — Posted: 2020-10-16
Additional analyses exploring the hypothesized transdifferentiation of plasmablasts to developing neutrophils in severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Martin, B. A., Rogers, A. J., Blish, C. A.
10.1101/2020.10.15.339473 — Posted: 2020-10-16
Early induction of SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
Tan, A. T., Linster, M., Tan, C., Le Bert, N., Chia, W., Kunasegaran, K., Zhuang, Y., Tham, C. Y., Chia, A., Smith, G. J., Young, B. E., Kalimuddin, S., Low, J. G., Lye, D., Wang, L.-F., Bertoletti, A.
10.1101/2020.10.15.341958 — Posted: 2020-10-16
Antibody Response to a Nucleocapsid Epitope as a Marker for COVID-19 Disease Severity
Sen, S., Sanders, E. C., Gabriel, K. N., Miller, B. M., Isoda, H. M., Salcedo, G. S., Garrido, J. E., Dyer, R. P., Nakajima, R., Jain, A., Santos, A. M., Bhuvan, K., Tifrea, D. F., Ricks-Oddie, J. L., Felgner, P. L., Edwards, R. A., Majumdar, S., Weiss, G. A.
10.1101/2020.10.15.341743 — Posted: 2020-10-16
Abnormal Antibodies to Self-Carbohydrates in SARS-CoV-2 Infected Patients
Butler, D. L., Gildersleeve, J. C.
10.1101/2020.10.15.341479 — Posted: 2020-10-16 Discussion: Onsite
Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models
Somogyi, E., Csiszovszki, Z., Molnar, L., Lorincz, O., Toth, J., Pattijn, S., Schockaert, J., Mazy, A., Miklos, I., Pantya, K., Pales, P., Toke, E. R.
10.1101/2020.10.16.339937 — Posted: 2020-10-16
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Rescher, U., Schloer, S., Brunotte, L., Mecate-Zambrano, A., Zheng, S., Tang, J., Ludwig, S.
10.1101/2020.10.16.342410 — Posted: 2020-10-16
How to remove the testing bias in CoV-2 statistics
Waelde, K.
10.1101/2020.10.14.20212431 — Posted: 2020-10-16
Early Prediction of COVID-19 Severity Using Extracellular Vesicles and Extracellular RNAs
Fujita, Y., Hoshina, T., Matsuzaki, J., Kadota, T., Fujimoto, S., Kawamoto, H., Watanabe, N., Sawaki, K., Sakamoto, Y., Miyajima, M., Lee, K., Nakaharai, K., Horino, T., Nakagawa, R., Araya, J., Miyato, M., Yoshida, M., Kuwano, K., Ochiya, T.
10.1101/2020.10.14.20212340 — Posted: 2020-10-16
The effect of influenza vaccination on trained immunity: impact on COVID-19
Debisarun, P. A., Struycken, P., Dominguez-Andres, J., Moorlag, S. J. C. F. M., Taks, E., Gössling, K. L., Ostermann, P. N., Müller, L., Schaal, H., ten Oever, J., van Crevel, R., Netea, M. G.
10.1101/2020.10.14.20212498 — Posted: 2020-10-16 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).